Regular follow-ups with your healthcare provider ensure that the treatment remains safe and effective, with adjustments made as necessary to optimize results and minimize risks
high blood pressure, diabetes, joint pain, high cholesterol, heart disease, etc)
This study was limited to the subgroup of patients with prediabetes with the primary aim to assess the proportion of individuals who developed T2D 18
GLP-1 slows gastric emptying (food stays in your stomach longer), increases satiety (you feel fuller faster), and reduces appetite
Semaglutide is usually quantified in doses for injection, which can lead to confusion when converting to milligrams (mg)
GLP-1 medications can reduce appetite to the point that nutritional intake drops too low